TNF and rheumatoid arthritis: Patients with RA with SS were more likely to be taking abatacept or other non-tumor necrosis factor inhibitor biologic/targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs) than patients with RA only.